Shedding MICA/B on tumor cell surfaces and subsequent soluble MICA/B can downregulate NKG2D expression on NK cells, which promotes tumor immune escape by impairing NK cell antitumor activity [76,77]. The gene discussed is MICA; the disease is neoplasm.